Drug Trial Radar · NCT06282575
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
286
Planned (sponsor's estimate)
Start
Jul 19, 2024
Primary completion
Dec 1, 2028
Study completion Apr 1, 2030
Sponsor
- Lead sponsor
- Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
- Sponsor type
- Industry
- First posted
- Feb 28, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of Zanidatamab plus CisGem (Cisplatin and Gemcitabine) with or without the addition of a programmed death protein 1/ligand-1 (PD-1/L1) inhibitor (physician's choice of either Durvalumab or Pembrolizumab, where approved under local regulations) as first line of treatment for participants with human epidermal growth factor receptor 2 (HER2)-positive biliary tract cancer.
Conditions
- Biliary Tract Cancer
Interventions
ZanidatamabDrug
Administered intravenously (IV)
CisplatinDrug
Administered intravenously (IV)
GemcitabineDrug
Administered intravenously (IV)
PembrolizumabDrug
Administered intravenously (IV)
DurvalumabDrug
Administered intravenously (IV)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression Free Survival (PFS) in participants with Immunohistochemistry (IHC) 3+ tumorsTime frame: Up to 52 months
Locations
185 sites in 25 countries. Site status is shown where the registry gives one.
City of Hope(City of Hope National Medical Center, City of Hope Medical Center)
Duarte, California · Recruiting
Rocky Mountain Cancer Centers, LLP
Lone Tree, Colorado · Withdrawn
AdventHealth Hematology and Oncology
Orlando, Florida · Recruiting
Winship Cancer Institute
Atlanta, Georgia · Recruiting
The University of Kansas Cancer Center - Westwood
Westwood, Kansas · Withdrawn
Norton Cancer Institute - Audubon
Louisville, Kentucky · Withdrawn
Ochsner Clinic Foundation
New Orleans, Louisiana · Withdrawn
Tufts Medical Center
Boston, Massachusetts · Withdrawn
University of Michigan Hospital
Ann Arbor, Michigan · Recruiting
Henry Ford Health System
Detroit, Michigan · Withdrawn
Minnesota Oncology Hematology, P.A.
Maple Grove, Minnesota · Withdrawn
Atlantic Health System/Morristown Medical Center
Morristown, New Jersey · Withdrawn
Laura and Isaac Perlmutter Cancer Center at NYU Langone - Ambulatory Care Center
New York, New York · Recruiting
Memorial Sloan Kettering Cancer Centers
New York, New York · Recruiting
Oregon Health and Science University
Portland, Oregon · Recruiting
Saint Francis Cancer Center
Greenville, South Carolina · Withdrawn
SCRI Oncology Partners
Nashville, Tennessee · Withdrawn
Texas Oncology - DFW
Dallas, Texas · Withdrawn
University of Texas Southwestern Medical Center
Dallas, Texas · Recruiting
The Univerrsity of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
Virginia Commonwealth University, VCU Health
Richmond, Virginia · Recruiting
Centro Médico Privado CEMAIC
Córdoba, Argentina · Recruiting
Hospital Italiano de Buenos Aires
Ciudad Autónoma de Buenos Aires (caba), Buenos Altes, Argentina · Recruiting
Fundación ARS Médica
San Salvador de Jujuy, Jujuy Province, Argentina · Recruiting
Centro de Investigaciónes Clínicas - Clínica Viedma
Viedma, Río Negro Province, Argentina · Recruiting
Hospital Provincial Del Centenario
Rosario, Santa Fe Province, Argentina · Completed
Instituto Médico de la Fundación Estudios Clínicos
Rosario, Santa Fe Province, Argentina · Recruiting
CAIPO Centro para la Atención Integral del Paciente Oncológico
San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting
Centro Médico en Oncología Clínica EXELSUS S.R.L
San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting
Imelda VZW
Bonheiden, Antwerpen, Belgium · Withdrawn
UZ Antwerpen
Edegem, Antwerpen, Belgium · Withdrawn
UZ Leuven
Leuven, Vlaams-Brabant, Belgium · Withdrawn
Hospital Nossa Senhora Da Conceição/Centro Integrado de Pesquisa em Oncologia CIPO-GHC
Porto Alegre, Brazil · Recruiting
Instituto Nacional de Cancer - INCA
Rio de Janeiro, Brazil · Recruiting
Liga Norte Riograndense Contra O Cancer
Natal, Rio Grande do Norte, Brazil · Recruiting
Hospital de Clinicas de Porto Alegre - HCPA
Porto Alegre, Rio Grande do Sul, Brazil · Recruiting
Irmandade Da Santa Casa de Misericordia de Porto Alegre - ISCMPA
Porto Alegrev, Rio Grande do Sul, Brazil · Recruiting
Fundação Pio XII Hospital de Amor de Barretos
Barretos, São Paulo, Brazil · Recruiting
Fundação Doutor Amaral Carvalho - Hospital Amaral Carvalho
Jaú, São Paulo, Brazil · Active not recruiting
Fundação Faculdade Regional de Medicina de São José do Rio Preto (FUNFARME)
São José do Rio Preto, São Paulo, Brazil · Recruiting
Showing 40 of 185 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.